Suppr超能文献

口服索他洛尔后的疗效及药代动力学观察

Observations on the efficacy and pharmacokinetics of sotalol after oral administration.

作者信息

Brown H C, Carruthers S G, Kelly J G, McDevitt D G, Shanks R G

出版信息

Eur J Clin Pharmacol. 1976 Mar 22;09(5-6):367-72. doi: 10.1007/BF00606550.

Abstract

The effects of sotalol after oral administration were measured on the tachycardia induced by strenuous exercise in normal subjects. Plasma sotalol levels were also determined. The oral administration of sotalol (50, 100, 200 and 400 mg) to 6 subjects produced a progressive reduction in the tachycardia induced by severe exercise. This was similar to the effects of 25, 50, 100, 200, 400 and 800 mg given to different subjects. Each increase in sotalol dose produced a successively greater reduction in exercise tachycardia. This did not appear to be maximum even with 800 mg. Oral sotalol was rapidly absorbed and produced peak blood levels in 2 - 3 hours. The plasma levels of sotalol measured 2 hours after the oral administration of 25 to 800 mg showed never more than a six-fold variation between different subject. The half-life of sotalol in plasma was 12.7 +/- SE 1.6 hours. There was a significant correlation between the logarithm of the plasma sotalol concentration and the percentage reduction of exercise heart rate. It is concluded that the oral administration of sotalol either once or twice daily (depending on dose level) will provide satisfactory 24-hour blockade of beta-adrenoceptors.

摘要

研究了口服索他洛尔对正常受试者剧烈运动诱发的心动过速的影响,并测定了血浆索他洛尔水平。给6名受试者口服索他洛尔(50、100、200和400毫克)后,剧烈运动诱发的心动过速逐渐减轻。这与给不同受试者服用25、50、100、200、400和800毫克的效果相似。索他洛尔剂量的每次增加都会使运动性心动过速的降低幅度依次增大。即使服用800毫克,这种降低似乎也未达到最大值。口服索他洛尔吸收迅速,2至3小时达到血药峰值。口服25至800毫克索他洛尔2小时后测得的血浆水平在不同受试者之间的差异从未超过6倍。索他洛尔在血浆中的半衰期为12.7±标准误1.6小时。血浆索他洛尔浓度的对数与运动心率降低的百分比之间存在显著相关性。结论是,每日口服一次或两次索他洛尔(取决于剂量水平)将能对β-肾上腺素能受体提供令人满意的24小时阻滞作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验